跳至主要内容
临床试验/CTRI/2025/01/079075
CTRI/2025/01/079075尚未招募不适用

Effectiveness Of Individualized Homoeopathic Medicines In The Treatment Of Non-alcoholic Fatty Liver Disease:A Prospective Single-arm Clinical Study

Dr Ancy Saj1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年2月3日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Serum ALT and serum AST level

研究概览

简要总结

A prospective single-arm study  to know the effectiveness of individualized homoeopathic medicines in Non-alcoholic fatty liver disease

OBJECTIVES-

Primary Objective:

  1. To assess the effectiveness of individualized Homoeopathic medicines in the treatment of NAFLD by evaluating change in serum ALT and serum AST

Secondary objective

  1. To find out the changes in grade level of NAFLD in ultrasonography after Homoeopathic medicines

  2. To determine the changes in Quality of Life WHO Quality of Life Scale-Brief in patients with NAFLD after homoeopathic intervention.

  3. To find out changes in BARD Score in patients with NAFLD to predict risk of  advanced fibrosis

• DIAGNOSTIC CRITERIA

• Liver function test

• Ultra sonogram(USG)of abdomen

• Procurement of medicines: Pharmacy of Nehru Homoeopathic Medical College and Hospital. If not available it will be provide from a GMP certified pharmacy

• Study duration: maximum 12 months

• Study design: Prospective open label single-arm clinical study.

• Sample size- Minimum 30 cases

研究设计

研究类型
Interventional

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Non-Alcoholic patients 2.Both male and female patients aged between 18-70 years.
  • 3.Patients with elevated Serum ALT 4.Patients with elevated serum AST 5.Ultrasonographically diagnosed cases of NAFLD.

排除标准

  • 1.Subjects with history of drug intake known to result in liver enzyme elevation 2.Patients with complications of like liver cirrhosis, hepatocellular carcinoma.
  • 3.Patients with cholelithiasis & cholecystitis.
  • 4 Pregnant and lactating women.

结局指标

主要结局

Serum ALT and serum AST level

时间窗: At baseline and at an interval of 3 months

次要结局

  • Comparing changes in Ultrasonography of Abdomen
  • Improvement in quality of life (WHO-QOL bref scale )(At baseline and at the end of study)
  • BARD SCORE(3 months)

研究者

发起方
Dr Ancy Saj
申办方类型
Other [[self]]
责任方
Principal Investigator
主要研究者

Dr Ancy Saj

Nehru Homoeopathic Medical College and Hospital

研究点 (1)

Loading locations...

相似试验